Loading the section
The price of Ascendis Pharma A/S - Ordinary Share (ASND) on October 9, 2026 is 230.01 USD, +3.29% on the day. Over 52 weeks the stock traded between 186.05 USD and 282.15 USD; the price now sits 38% of the way up that range. Over the past year the price changed by +6.11%.
Prices delayed by 15 minutes
Next earnings report: none scheduled in the next five weeks · Earnings calendar
Ascendis Pharma A/S - Ordinary Share trades on Nasdaq under the ticker ASND. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks ASND has traded between 186.05 $ and 282.15 $. As of 09 October 2026 the price stood 38.12 % of the way from the 52-week low to the high.
Over one year ASND shares rose 6.11 %; over six months they fell 7.87 %. Volatility over 90 days is 39.50 %. Dividends are not included: this is price change only, as of 09 October 2026.
Ascendis Pharma A/S - Ordinary Share reported revenue of 720M € and a net loss of 228M € for the latest fiscal year. Net margin is −31.67 %. Revenue changed by +98.03 % year over year. Earnings per share are −3.76 €.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 09 October 2026 | 225.08 | 233.96 | 223.96 | 229.23 | 815,700 |
| 08 October 2026 | 227.83 | 227.98 | 219.52 | 222.69 | 924,100 |
| 07 October 2026 | 224.36 | 229.00 | 223.05 | 228.41 | 820,500 |
| 06 October 2026 | 229.21 | 230.91 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the fiscal year ended 31 December 2025
The sector median covers every company in the sector on the US market, loss-making ones included.
Share count is a period average, so market cap is approximate.
Ascendis Pharma A/S - Ordinary Share (ASND) is a public company in the healthcare sector. Its common stock trade on NASDAQ.
Over the trailing twelve months as reported to 2025-12-31, revenue was 720.1m €, net income was -228.0m €. Incorporated in DK.
This summary is compiled automatically from SEC filings and exchange data.
Address:TUBORG BOULEVARD 12, HELLERUP
| 1.2B |
| PFEPfizer, Inc. | 28.18 | +1.28 % | 929M |
| ABTAbbott Laboratories | 99.60 | +1.13 % | 921M |
| BMYBristol-Myers Squibb Company | 59.12 | −0.77 % | 714M |
| REGNRegeneron Pharmaceuticals, Inc. | 746.54 | +0.94 % | 555M |
| 222.72 |
| 226.05 |
| 1M |
| 05 October 2026 | 229.66 | 230.73 | 226.84 | 228.03 | 783,200 |
| 02 October 2026 | 227.63 | 229.02 | 225.20 | 227.87 | 641,400 |
| 01 October 2026 | 228.03 | 229.88 | 226.00 | 227.31 | 805,900 |
| 30 September 2026 | 227.97 | 230.97 | 226.18 | 227.83 | 926,200 |
| 29 September 2026 | 227.42 | 229.89 | 223.70 | 228.07 | 741,900 |
| 28 September 2026 | 226.00 | 231.14 | 224.81 | 230.05 | 747,500 |
| 25 September 2026 | 230.13 | 230.43 | 224.26 | 225.60 | 420,000 |
| 24 September 2026 | 223.00 | 231.13 | 220.23 | 230.70 | 1M |
| 23 September 2026 | 236.83 | 237.98 | 220.60 | 223.13 | 1M |
| 22 September 2026 | 239.09 | 240.69 | 234.67 | 237.57 | 548,300 |
| 21 September 2026 | 238.66 | 241.51 | 237.00 | 237.59 | 823,000 |
| 18 September 2026 | 238.15 | 243.68 | 236.02 | 236.72 | 2M |
| 17 September 2026 | 249.23 | 249.23 | 237.13 | 239.04 | 1M |
| 16 September 2026 | 239.70 | 249.01 | 237.23 | 247.69 | 1M |
| 15 September 2026 | 257.17 | 257.53 | 228.56 | 239.77 | 3M |
| 14 September 2026 | 265.00 | 265.50 | 260.00 | 264.92 | 416,300 |